Phio Pharmaceuticals Corp (PHIO)

Jul 15, 2025

What makes Phio Pharmaceuticals Corp. stock price move sharplySmart Growth Low Risk Picks - Newser

Jul 15, 2025

Jul 15, 2025

Why Phio Pharmaceuticals Corp. stock attracts strong analyst attentionDaily Swing Candidates - Newser

Jul 15, 2025

Jul 15, 2025

How Phio Pharmaceuticals Corp. stock performs during market volatilityFree Financial Group - Newser

Jul 15, 2025

Jul 08, 2025

Phio Pharmaceuticals Announces 2025 Annual Meeting Details - The Globe and Mail

Jul 08, 2025

Jul 08, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 6.3% – Here’s Why - Defense World

Jul 08, 2025

Jun 26, 2025

Phio Pharma stock maintains buy rating as cancer trial advances By Investing.com - Investing.com UK

Jun 26, 2025

Jun 25, 2025

Phio's Skin Cancer Drug Shows 44% Complete Response Rate, Final Trial Phase Begins - Stock Titan

Jun 25, 2025

Jun 24, 2025

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Yahoo Finance

Jun 24, 2025

Jun 12, 2025

Phio Pharmaceuticals Announces Strategic Initiative and Leadership Changes - TipRanks

Jun 12, 2025

Jun 12, 2025

Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial OfficerSEC Filing - MarketScreener

Jun 12, 2025

Jun 09, 2025

Research Analysts Set Expectations for PHIO FY2025 Earnings - Defense World

Jun 09, 2025

Jun 07, 2025

What is HC Wainwright’s Forecast for PHIO Q2 Earnings? - Defense World

Jun 07, 2025

Jun 06, 2025

Phio Pharmaceuticals appoints new strategic and finance VPs By Investing.com - Investing.com South Africa

Jun 06, 2025

Jun 06, 2025

Phio Pharmaceuticals appoints new strategic and finance VPs - Investing.com India

Jun 06, 2025

Jun 06, 2025

Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio - TradingView

Jun 06, 2025

Jun 06, 2025

Phio Pharmaceuticals Advances 30-Drug Cancer Portfolio as Phase 1b Trial Shows Promise - Stock Titan

Jun 06, 2025

Jun 06, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Now Covered by HC Wainwright - Defense World

Jun 06, 2025

Jun 05, 2025

Phio Pharma (PHIO) Receives Buy Rating and $14 Price Target from HC Wainwright | PHIO Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

H.C. Wainwright assumes coverage on Phio Pharma stock with Buy rating - Investing.com India

Jun 05, 2025

Jun 05, 2025

Phio Pharmaceuticals (PHIO) Gains 'Buy' Rating with Promising Pr - GuruFocus

Jun 05, 2025

Jun 03, 2025

2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now - The Globe and Mail

Jun 03, 2025

Jun 02, 2025

Why BioNTech Stock Soared Today - The Globe and Mail

Jun 02, 2025

May 28, 2025

Best Value Stocks to Buy for May 28th - The Globe and Mail

May 28, 2025

May 28, 2025

New Strong Buy Stocks for May 28th - The Globe and Mail

May 28, 2025

May 27, 2025

AI Momentum Stocks: 3 Breakout Companies (ASML, PLTR, AVGO) - The Globe and Mail

May 27, 2025

May 26, 2025

New Strong Buy Stocks For May 28th - Barchart.com

May 26, 2025

May 26, 2025

2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster Potential - The Globe and Mail

May 26, 2025

May 23, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Trading 2.8% Higher – Time to Buy? - Defense World

May 23, 2025

May 19, 2025

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference - Newsfile

May 19, 2025

May 19, 2025

Phio Reveals Latest Progress on Revolutionary Cancer-Fighting siRNA Technology at Investor Conference - Stock Titan

May 19, 2025

May 15, 2025

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - Newsfile

May 15, 2025

May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025

May 07, 2025

Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks

May 07, 2025

May 07, 2025

Phio reports positive results in skin cancer trial - Investing.com

May 07, 2025

May 07, 2025

Phio reports positive results in skin cancer trial By Investing.com - Investing.com India

May 07, 2025

May 07, 2025

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial - Newsfile

May 07, 2025

May 01, 2025

Phio Pharmaceuticals (PHIO) to Release Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Elon Musk Could Bring Nvidia Stock $20 Billion Worth of Good News - The Globe and Mail

Apr 30, 2025

Apr 24, 2025

Best Value Stocks to Buy for April 23rd - NewsBreak: Local News & Alerts

Apr 24, 2025

Apr 23, 2025

Analysts Advise You To Maintain Your Position In Phio Pharmaceuticals Corp (NASDAQ: PHIO) - Stocksregister

Apr 23, 2025

Apr 23, 2025

Best Momentum Stocks to Buy for April 23rd - TradingView

Apr 23, 2025

Apr 23, 2025

Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX

Apr 23, 2025